gnipst bulletin 25.2

Upload: gnipst-bulletin

Post on 14-Apr-2018

223 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/30/2019 Gnipst Bulletin 25.2

    1/15

    1118-1177-4796-9849-7562-5062mail

    GNIPST BULLETIN 2013

    17th MAY 2013 Volume No.: 25 Issue No.: 02

    ContentsMessage from GNIPS

    Letter to the EditorNews Update

    Disease Outbreak Ne

    Health Awareness

    Forth Coming Events

    Drugs Update

    Campus News

    Students Section

    Editors Note

    Archive

    Vision

    TO GROW AS A CENTRE OF EXCELLENCE IN THE FIELD O

    PHARMACEUTICAL AND BIOLOGICAL SCIENCE

    EDITOR: Debabrata Ghosh DastidarGURU NANAK INSTITUTE OF PHARMACEUTICAL SCIENCE AND

    TECHNOLOGY

    GNIPST Photo Gallery

    For your comments/contributionOR

    For Back-Issues,

    mailto:[email protected]

    1

    https://picasaweb.google.com/111714720327580099858/SeminarPresentationmailto:[email protected]:[email protected]:[email protected]://picasaweb.google.com/111714720327580099858/SeminarPresentation
  • 7/30/2019 Gnipst Bulletin 25.2

    2/15

    17-05-2013

    MESSAGE FROM GNIPSTAll the members of GNIPST are proud to publish the 25th Volume of

    GNIPST BULLETIN. This bulletin has successfully completed its

    twenty four months journey. We hope it has kept the readers updated

    of recent activities in pharmaceutical & biological sciences and also

    introduced them with the different activities of our esteemed

    institution. We are thankful to all of you for your great cooperation

    & support and are looking forward to the same in future.

    LETTER TO THE EDITOR.

    NEWS UPDATE

    WORLD NO TOBACCODAY: 31 MAY, 2013Every year, on 31 May, WHO and partners mark World No Tobacco

    Day, highlighting the health risks associated with tobacco use and

    advocating for effective policies to reduce tobacco consumption.

    Tobacco kills nearly six million people each year, of which more

    than 600 000 are non-smokers dying from breathing second-hand

    smoke. The theme of this years campaign is "Ban tobacco

    advertising, promotion and sponsorship".Read more

    Click here to go at the top1

    http://www.who.int/campaigns/no-tobacco-day/2013/event/en/index.htmlhttp://www.who.int/campaigns/no-tobacco-day/2013/event/en/index.htmlhttp://www.who.int/campaigns/no-tobacco-day/2013/event/en/index.htmlhttp://www.who.int/campaigns/no-tobacco-day/2013/event/en/index.html
  • 7/30/2019 Gnipst Bulletin 25.2

    3/15

    17-05-2013

    New Device Can Extract Human DNA With Full

    Genetic Data in Minutes (06 MAY 2013)

    Engineers have created a device that can extract human DNA fromfluid samples in a simpler, more efficient and environmentally

    friendly way than conventional methods.Read more

    Ubiquitous Engineered Nanomaterials Can Cause

    Lung Inflammation:Substances Are Used in

    Everything from Paint to Sporting Equipment(06 MAY 2013)

    Scientists have found that breathing ultrafine particles from a large

    family of materials that increasingly are found in a host of household

    and commercial products, from sunscreens to the ink in copy

    machines to super-strong but lightweight sporting equipment, cancause lung inflammation and damage.Read more

    Possible Treatment for Serious Blood Cancer

    (06 MAY 2013)

    A single antibody could be the key to treating multiple myeloma, or

    cancer of the blood, currently without cure or long-term treatment.

    New tests have shown that the antibody is able to destroy myeloma

    cells.Read more

    Click here to go at the top2

    http://www.sciencedaily.com/releases/2013/05/130506132100.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506132100.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506103308.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506103308.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506095301.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506095301.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506095301.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506103308.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506132100.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29
  • 7/30/2019 Gnipst Bulletin 25.2

    4/15

    17-05-2013

    Endogenous Antibiotic Discovered in the Brain?

    (06 MAY 2013)

    Scientists have discovered that immune cells in the brain can

    produce a substance that prevents bacterial growth: namely

    itaconic acid. Until now, biologists had assumed that only certain

    fungi produced itaconic acid. Scientists have now shown that even

    so-called microglial cells in mammals are also capable of producing

    this acid.Read moreBrain Anatomy of Dyslexia Is Not the Same in

    Men and Women, Boys and Girls (08 MAY 2013)

    Using MRI, neuroscientists have found significant differences in

    brain anatomy when comparing men and women with dyslexia to

    their non-dyslexic control groups. Their study is the first to directlycompare brain anatomy of females with and without dyslexia.Readmore

    Biosensor That Detects Antibiotic Resistance

    Brings Us One Step Closer to Fighting Superbugs.

    (08 MAY 2013)

    New research demonstrates how a biosensor can detect antibiotic

    resistance in bacteria. This new technology is a preliminary step in

    identifying and fighting superbugs, a major public health concern

    Click here to go at the top3

    http://www.sciencedaily.com/releases/2013/05/130506095253.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506095253.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506095253.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130508131831.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130508131831.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130508131831.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130508131831.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130508131831.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130508131831.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130506095253.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29
  • 7/30/2019 Gnipst Bulletin 25.2

    5/15

    17-05-2013

    that has led to more deaths than AIDS in the United States in recent

    years.Read moreUsing Bacteria to Stop Malaria (09 MAY 2013)

    Mosquitoes are deadly efficient disease transmitters. New research

    however, demonstrates that they also can be part of the solution for

    preventing diseases such as malaria.Read more 'Magic Bullet Nanomedicine Developed for Acute

    Lung Injury(14MAY 2013

    )Researchers have devised a magic bullet nanomedicine which

    could become the first effective treatment for Acute Lung Injury or

    ALI, a condition affecting 20 per cent of all patients in intensive

    care.Read moreVitamin C Does Not Lower Uric Acid Levels in

    Gout Patients, Study Finds(16 MAY 2013)

    Despite previous studies touting its benefit in moderating gout risk,

    new research reveals that vitamin C, also known ascorbic acid, does

    not reduce uric acid (urate) levels to a clinically significant degree

    in patients with established gout. Vitamin C supplementation,

    alone or in combination with allopurinol, appears to have a weak

    effect on lowering uric acid levels in gout patients, according to the

    results of a new study.Read more

    Click here to go at the top4

    http://www.sciencedaily.com/releases/2013/05/130508102552.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130508102552.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130509142106.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130509142106.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130514213107.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130514213107.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130516063734.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130516063734.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130516063734.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130514213107.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130509142106.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29http://www.sciencedaily.com/releases/2013/05/130508102552.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine+%28ScienceDaily%3A+Health+%26+Medicine+News%29
  • 7/30/2019 Gnipst Bulletin 25.2

    6/15

    17-05-2013

    HEALTH AWARENESS

    TOBACCO

    Leading cause of death, illness and impoverishment

    The tobacco epidemic is one of the biggest public health threats the world

    has ever faced. It kills nearly 6 million people a year of whom more than 5

    million are from direct tobacco use and more than 600 000 are nonsmokers

    exposed to second-hand smoke. Approximately one person dies every six

    seconds due to tobacco and this accounts for one in 10 adult deaths. Up tohalf of current users will eventually die of a tobacco-related disease.

    Nearly 80% of the more than one billion smokers worldwide live in low-

    and middle-income countries, where the burden of tobacco-related illness

    and death is heaviest.

    Tobacco users who die prematurely deprive their families of income, raise

    the cost of health care and hinder economic development.

    In some countries, children from poor households are frequently employed

    in tobacco farming to provide family income. These children are especially

    vulnerable to "green tobacco sickness", which is caused by the nicotine that

    is absorbed through the skin from the handling of wet tobacco leaves.Gradual killer

    Click here to go at the top5

  • 7/30/2019 Gnipst Bulletin 25.2

    7/15

    17-05-2013

    Because there is a lag of several years between when people start using

    tobacco and when their health suffers, the epidemic of tobacco-related

    disease and death has just begun.

    Tobacco caused 100 million deaths in the 20th century. If current trends

    continue, it may cause about one billion deaths in the 21st century.

    Unchecked, tobacco-related deaths will increase to more than eight

    million per year by 2030. More than 80% of those deaths will be in low- and

    middle-income countries.

    Surveillance is key

    Good monitoring tracks the extent and character of the tobacco epidemic

    and indicates how best to tailor policies. Only fifty-nine countries,

    representing under half of the world's population, monitor tobacco use by

    repeating nationally representative youth and adult surveys at least once

    every five years.

    Second-hand smoke kills

    Second-hand smoke is the smoke that fills restaurants, offices or other

    enclosed spaces when people burn tobacco products such as cigarettes,

    bidis and water pipes. There are more than 4000 chemicals in tobacco

    smoke, of which at least 250 are known to be harmful and more than 50 areknown to cause cancer.

    There is no safe level of exposure to second-hand tobacco smoke.

    Click here to go at the top6

  • 7/30/2019 Gnipst Bulletin 25.2

    8/15

    17-05-2013

    In adults, second-hand smoke causes serious cardiovascular and

    respiratory diseases, including coronary heart disease and lung cancer. In

    infants, it causes sudden death. In pregnant women, it causes low birth

    weight.Almost half of children regularly breathe air polluted by tobacco smoke

    in public places.

    Over 40% of children have at least one smoking parent.

    Second-hand smoke causes more than 600 000 premature deaths per

    year.

    In 2004, children accounted for 28% of the deaths attributable to second-

    hand smoke.

    Every person should be able to breathe smoke-free air. Smoke-free laws

    protect the health of non-smokers, are popular, do not harm business and

    encourage smokers to quit.

    Under 11% of the world's population are protected by comprehensive

    national smoke-free laws.

    The number of people protected from second-hand smoke more than

    doubled to 739 million in 2010 from 354 million in 2008.

    Tobacco users need help to quit

    Studies show that few people understand the specific health risks of

    tobacco use. For example, a 2009 survey in China revealed that only 38% of

    smokers knew that smoking causes coronary heart disease and only 27%

    knew that it causes stroke.

    Click here to go at the top7

  • 7/30/2019 Gnipst Bulletin 25.2

    9/15

    17-05-2013

    Among smokers who are aware of the dangers of tobacco, most want to

    quit. Counselling and medication can more than double the chance that a

    smoker who tries to quit will succeed.

    National comprehensive health-care services supporting cessation are

    available in only 19 countries, representing 14% of the world's population.

    There is no cessation assistance in 28% of low-income countries and 7% of

    middle-income countries.

    Picture warnings work

    Hard-hitting anti-tobacco advertisements and graphic pack warnings

    especially those that include pictures reduce the number of children who

    begin smoking and increase the number of smokers who quit.

    Graphic warnings can persuade smokers to protect the health of non-

    smokers by smoking less inside the home and avoiding smoking near

    children. Studies carried out after the implementation of pictorial package

    warnings in Brazil, Canada, Singapore and Thailand consistently show that

    pictorial warnings significantly increase people's awareness of the harms of

    tobacco use.

    Mass media campaigns can also reduce tobacco consumption, by

    influencing people to protect non-smokers and convincing youths to stop

    using tobacco.

    Click here to go at the top8

  • 7/30/2019 Gnipst Bulletin 25.2

    10/15

    17-05-2013

    Just 19 countries, representing 15% of the world's population, meet the best

    practice for pictorial warnings, which includes the warnings in the local

    language and cover an average of at least half of the front and back of

    cigarette packs. No low-income country meets this best-practice level.Forty-two countries, representing 42% of the worlds population, mandate

    pictorial warnings.

    More than 1.9 billion people, representing 28% of the world's population,

    live in the 23 countries that have implemented at least one strong anti-

    tobacco mass media campaign within the last two years.

    Ad bans lower consumption

    Bans on tobacco advertising, promotion and sponsorship can reduce

    tobacco consumption.

    A comprehensive ban on all tobacco advertising, promotion and

    sponsorship could decrease tobacco consumption by an average of about

    7%, with some countries experiencing a decline in consumption of up to

    16%.

    Only 19 countries, representing 6% of the worlds population, have

    comprehensive national bans on tobacco advertising, promotion and

    sponsorship.

    Around 38% of countries have minimal or no restrictions at all on tobaccoadvertising, promotion and sponsorship.

    Taxes discourage tobacco use

    Click here to go at the top9

  • 7/30/2019 Gnipst Bulletin 25.2

    11/15

    17-05-2013

    Tobacco taxes are the most effective way to reduce tobacco use, especially

    among young people and poor people. A tax increase that increases tobacco

    prices by 10% decreases tobacco consumption by about 4% in high-income

    countries and by up to 8% in low- and middle-income countries.Only 27 countries, representing less than 8% of the world's population,

    have tobacco tax rates greater than 75% of the retail price.

    Tobacco tax revenues are on average 154 times higher than spending on

    tobacco control, based on available data.

    DISEASE OUTBREAK NEWS

    FORTHCOMING EVENTS

    AICTE Sponsored National Seminar on "EMERGING TRENDS AND

    INNOVATIONS IN DRUG DELIVERY AND PHARMACEUTICAL

    SCIENCES".

    Date: 19th May. 2013.

    Venue: Columbia Institute of Pharmacy, Raipur, CG, India

    Registration form

    Click here to go at the top10

    http://www.columbiaiop.ac.in/seminar/aicte_national_reg2013.pdfhttp://www.columbiaiop.ac.in/seminar/aicte_national_reg2013.pdf
  • 7/30/2019 Gnipst Bulletin 25.2

    12/15

    17-05-2013

    DRUGS UPDATES

    FDA approves Simponi to treat ulcerative colitis

    (15 MAY 2013)

    The U.S. FDA approved a new use for Simponi (golimumab)

    injection to treat adults with moderate to severe ulcerative

    colitis.Read more FDA approves new drug for advanced prostate

    cancer(15 MAY 2013)

    Xofigo (radium Ra 223 dichloride) to treat men with symptomatic

    late-stage (metastatic) castration-resistant prostate cancer that has

    spread to bones but not to other organs. It is intended for men

    whose cancer has spread after receiving medical or surgical therapy

    to lower testosterone.Read more.CAMPUS NEWS

    JOB OPPOURTUNITY

    There is vacancy for the post of Medical Representative in Eisai

    Pharmaceuticals India Pvt. Ltd. The interested B.Pharm. pass out

    students are required to contact Mr. Abir Koley (8017445495)

    immediately.

    Click here to go at the top11

    http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352383.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352383.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352363.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352363.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352363.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352363.htmhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm352383.htm
  • 7/30/2019 Gnipst Bulletin 25.2

    13/15

    17-05-2013

    STUDENTS SECTION

    WHO CAN ANSWER FIRST???() Arne Larsson was famous as a first patient of

    which implanted device?

    () Albert Ladenburg in 1980 isolated whichalkaloid?

    Answer of Previous Issue Question:A) Prednisone B)Methotrexate

    Send your thoughts/ Quiz/Puzzles/games/write-ups or any other contributions for Students Section

    & answers of this Section at [email protected] NOTE

    I am very happy to publish the 2nd issue of 25th Volume of GNIPST

    BULLETIN. It is my great pleasure to introduce you to the newly

    launchedfacebook account GNIPST bulletin. You are cordially

    invited to add this account to your friend list. The current issues will

    also be directly available on facebook.

    I would like to convey my thanks to all the GNIPST members and

    the readers for their valuable comments, encouragement& supports.

    Click here to go at the top12

    mailto:[email protected]:[email protected]:[email protected]
  • 7/30/2019 Gnipst Bulletin 25.2

    14/15

    17-05-2013

    Special thanks to Dr. Prerona Saha for her advice; Mr. Soumya

    Bhattacharya, for his contribution in students section.

    It would be my great pleasure to receive the contributions,

    suggestions & feedback from your desk for further upliftment of this

    deliberation GNIPST BULLETIN.

    ARCHIVE

    The general body meeting of APTI, Bengal Branch has been

    conducted at GNIPST on 15th June, 2012. The programme started

    with a nice presentation by Dr. Pulok Kr. Mukherjee, School of

    Natural Products, JU on the skill to write a good manuscript for

    publication in impact journals. It was followed by nearly two hour

    long discussion among more than thirty participants on different

    aspects of pharmacy education. Five nonmember participants

    applied for membership on that very day.

    GNIPST is now approved by AICTE and affiliated to WBUT for

    conducting the two years post graduate course (M.Pharm) in

    PHARMACOLOGY. The approved number of seat is 18.

    The number of seats in B.Pharm. has been increased from 60 to 120.

    2nd World Congress on Ga-68 (Generators and Novel Radiopharmaceuticals),

    Molecular Imaging (PET/CT), Targeted Radionuclide Therapy, and Dosimetry

    (SWC-2013) : On the Way to Personalized Medicine

    Click here to go at the top13

  • 7/30/2019 Gnipst Bulletin 25.2

    15/15

    17-05-2013

    Dates 28 Feb 2013 02 Mar 2013

    Location: Chandigarh, India.Details.

    AICTE has sanctioned a release of grant under Research

    Promotion Scheme (RPS) during the financial year 2012-

    13to GNIPST as per the details below:

    a. Beneficiary Institution: Guru Nanak Institution of

    Pharmaceutical Science & Technology.

    b. Principal Investigator: Dr. Lopamudra Dutta.

    c. Grant-in-aid sanctioned: Rs. 16,25000/- only

    d.Approved duration: 3 years

    e. Title of the project: Screening and identification of potential

    medicinal plant ofPurulia &Bankura districts of West Bengal with

    respect to diseases such as diabetes, rheumatism, Jaundice,

    hypertension and developing biotechnological tools for enhancing

    bioactive molecules in these plant.

    Click here to go at the top14

    http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/http://www.2ndworldcongress-ga-68.de/